35 Results for "

parp1/2

" in MedChemExpress (MCE) Product Catalog:
Products (35)

35 Results for "parp1/2" in MCE Product Catalog:

  • Isoforms Recommended:
  • Targets Recommended:
Cat. No.: HY-161606
CAS No.: 3034665-49-8
Target:  

PARP

Research Areas:  

Cancer

PARP-1/2/7-IN-1 (compound 86) is a potent inhibitor of PARP-1/2/7, with the IC50 of < 10 nM .
loading...
    loading...
Cat. No.: HY-145328
CAS No.: 1903744-45-5
Target:  

PARP

Research Areas:  

Others

PARP-1/2-IN-1 is a potent PARP-1/2 inhibitor with IC50 of 0.51 nM and 23.11 nM, respectively.
loading...
    loading...
Cat. No.: HY-179349
CAS No.: 489457-75-2
Target:  

PARP

PARP-1/2-IN-5 (Compound 12) is a PARP-1/2 inhibitor, with the IC50 values for PARP-1 and PARP-2 being 118 and 11 nM respectively. PARP-1/2-IN-5 can be used for the study of inflammatory diseases and neurodegenerative disorders [1].
loading...
    loading...
Cat. No.: HY-171543
CAS No.: 952474-39-4
Target:  

PARP

Research Areas:  

Cancer

PARP1-IN-37 (Compound 8) is an orally active and selective poly(ADP-ribose) polymerase 1 and 2 (PARP1/2) inhibitor with an IC50 value of 24 nM for PARP1. PARP1-IN-37 inhibits PARP activity in cells with an EC50 value of 3.7 μM. PARP1-IN-37 is promising for research of BRCA-mutated tumors, such as breast and ovarian cancers [1].
loading...
    loading...
Cat. No.: HY-145734A
CAS No.: 2923879-23-4
Purity:  98.05%
Target:  

Microtubule/Tubulin

Research Areas:  

Cancer

AMXI-5001 hydrochloride is a potent, orally active, and dual parp1/2 and microtubule polymerization inhibitor. MXI-5001 hydrochloride exhibits selective antitumor cytotoxicity across a wide variety of human cancer cells with much lower IC50s than existing clinical PARP1/2 inhibitors. AMXI-5001 hydrochloride induces complete regression of established tumors, including exceedingly large tumors [1].
loading...
    loading...
Cat. No.: HY-13688R
CAS No.: 344458-15-7
Target:  

PARP

Research Areas:  

Cancer

PJ34 (hydrochloride) (Standard) is the analytical standard of PJ34 (hydrochloride). This product is intended for research and analytical applications. PJ34 hydrochloride is an inhibitor of PARP1/2 with IC50 of 110 nM and 86 nM, respectively.
loading...
    loading...
Cat. No.: HY-137450A
CAS No.: 1401683-39-3
Synonyms: IMP4297 hydrochloride; JS109 hydrochloride
Target:  

PARP

Research Areas:  

Cancer

Senaparib hydrochloride (IMP4297 hydrochloride) is an oral, selective PARP1/2 inhibitor with potent anti-tumor activity. Senaparib hydrochloride shows antitumor activity against advanced ovarian cancer [1].
loading...
    loading...
Cat. No.: HY-14687
CAS No.: 1207454-56-5
Synonyms: (rac)-BMN-673; (rac)-LT-673
Target:  

PARP

Research Areas:  

Cancer

(rac)-Talazoparib ((rac)-BMN-673) (Compound 47) is the orally active inhibitor for PARP1/2 with Ki of 1.2 nM and 0.87 nM. (rac)-Talazoparib inhibits cellular PARylation with an EC50 of 2.51 nM. (rac)-Talazoparib causes the accumulation of DNA damage, inhibits proliferation of BRCA1/2-mutated MX-1 cell and Capan-1 cell with IC50 of 0.3 nM and 5 nM. (rac)-Talazoparib exhibits antitumor efficacy in mouse models [1].
loading...
    loading...
Cat. No.: HY-156419
CAS No.: 2435657-10-4
Purity:  ≥95.0%
Target:  

PARP

Research Areas:  

Cancer

PARP7-IN-16 (compound 36) is a potent, selective and orally active inhibitor of PARP-1/2/7, with IC50s of 0.94, 0.87 and 0.21 nM, respectively. PARP7-IN-16 can be used for the research of breast cancer and prostate cancer .
loading...
    loading...
Cat. No.: HY-172747
CAS No.: 2580941-64-4
Target:  

PARP

Research Areas:  

Cancer

TNKS-2-IN-3 (Compound 5) is a selective competitive tankyrase 2 (TNKS2) inhibitor with an IC50 value of 0.3 nM, showing over 20-fold selectivity over TNKS1 and more than 100-fold selectivity over PARP1/2. TNKS-2-IN-3 stabilizes axin and suppresses the Wnt/β-catenin pathway by inhibiting TNKS2-mediated ADP-ribosylation, exhibiting antiproliferative activity in colorectal cancer cells. TNKS-2-IN-3 is proming for rasearch of solid tumors with aberrant Wnt pathway activation, such as colorectal cancer [1].
loading...
    loading...
Cat. No.: HY-108413R
CAS No.: 1373431-65-2
Synonyms: BMN 673ts (Standard)
Research Areas:  

Cancer

Talazoparib tosylate (Standard) is the analytical standard of Talazoparib tosylate (HY-108413). This product is intended for research and analytical applications. Talazoparib tosylate (BMN 673ts) is a novel, potent and orally available PARP1/2 inhibitor with an IC50 of 0.57 nM for PARP1.
loading...
    loading...
Cat. No.: HY-155458
CAS No.: 1201832-32-7
Target:  

PARP

Research Areas:  

Inflammation/Immunology Cancer

HYDAMTIQ is a PARP-1/2 inhibitor (IC50: 29-38 nM) with anticancer, anti-inflammatory, and ischemic protective effects. HYDAMTIQ inhibits pulmonary PARP activity, is effective against allergen-induced cough and dyspnea, and inhibits bronchial hyperresponsiveness to methacholine. HYDAMTIQ has broad-spectrum tumor suppressor effects, including ovarian and breast cancers, prostate and pancreatic tumors, and glioblastoma multiforme. HYDAMTIQ has demonstrated in vivo efficacy in animal models of cerebral ischemia, asthma, cancer, and more [1].
loading...
    loading...
Cat. No.: HY-130646
CAS No.: 2472645-27-3
Target:  

PROTACs PARP

Research Areas:  

Cancer

iVeliparib-AP6 is a proteolysis-targeting chimera (PROTAC) molecule designed based on Veliparib (HY-10129), which targets PARP1/2. The DC50s of iVeliparib-AP6 for inducing the degradation of PARP1 and PARP2 are 36 nM and 63 nM, respectively, and its IC50s are 69 nM and 21 nM, respectively. iVeliparib-AP6 contains a Veliparib-based PARP inhibitor warhead linked to a CRBN E3 ligase binder; it uses Thalidomide (HY-14658) as a ligand to recruit CRBN E3 ubiquitin ligase and exerts the PARP2 degradation mechanism [1] .
loading...
    loading...
Cat. No.: HY-180809
CAS No.: 3049753-10-5
Target:  

PARP

Research Areas:  

Cancer

YCH3292, a derivative of YCH189 (HY-155993) is a potent, selective and orally active PARP1/2 inhibitor with IC50 both <0.001 nM. YCH3292 can increase the stability of PARP-DNA complexes. YCH3292 exhibits robust antiproliferative activity. YCH3292 can induce double-strand breaks in DNA, increase the protein levels of γH2AX, P-RPA32, and P-Chk1 and induce tumor cells S or G2/M phase arrest and apoptosis. YCH3292 can inhibit tumor growth in MC38 xenograft model [1].
loading...
    loading...
Cat. No.: HY-145584A
CAS No.: 2055357-65-6
Synonyms: JPI-547/OCN-201 hydrochloride
Target:  

PARP Wnt β-catenin

Research Areas:  

Cancer

Nesuparib (JPI-547) hydrochloride is the orally active inhibitor for PARP 1/2 and Tankyrase 1/2 that inhibits tankyrases 1, tankyrases 2, and PARP 1 with IC50s of 5, 1 and 2 nM, respectively. Nesuparib hydrochloride exhibits antitumor activity and can be used in research of advanced solid tumor [1] .
loading...
    loading...